Aspergillus tracheobronchitis in COVID-19 patients with acute respiratory distress syndrome: a cohort study

Eur Respir J. 2022 May 5;59(5):2103142. doi: 10.1183/13993003.03142-2021. Print 2022 May.

Abstract

Comprehensive work-up is needed for COVID-19 ARDS patients, especially when suspecting invasive fungal infections. Aspergillus tracheobronchitis has a substantial prevalence in patients with CAPA accounting for an overall mortality of 75% in this study. https://bit.ly/3uF3FZU

Trial registration: ClinicalTrials.gov NCT01731353.

Publication types

  • Letter

MeSH terms

  • Aspergillosis*
  • Aspergillus
  • Bronchitis* / complications
  • COVID-19* / complications
  • Cohort Studies
  • Humans
  • Respiratory Distress Syndrome* / complications
  • Tracheitis* / complications

Associated data

  • ClinicalTrials.gov/NCT01731353